Cell Wall Inhibitors Flashcards
Penicillin G & V spectrum
Gram (+) microbes have the greatest activity
gram (-) cocci -> not as good because need to get through cell wall where B-lactamase is waiting
and non-B-lactamase producing anaerobes
Susceptible to B-lactamase activity
B-lactamase resistant penicillins spectrum
Nafcillin, Dicloxacilliin
Against Strep, staph, pneunmococci
No activity against enterococci and anaerobes or gram (-) rods or cocci
Aminopenicillins and extended spectrum penicillins
amoxicillin, ampicillin
similar to penicillin in spectrum
BUT WITH GREATER ACTIVITY AGAINST GRAM (-)
often with B-lactamase inhibitors like clavulanic acid (increases the activity of the abx)
Indication and drug of choice for Penicillin G
Streptococci, Meningococci, PEN- susceptible pneumococci
for Antrax, diptheria, C. difficile, syphillis, meningitis
Indication and drug of choice for Penicillin V
Poor availability -> mild infections
Step. A,C,G (pharyngitis and tonsilitis)
PEN -sensitive S. pneumonaie
Clinical uses for Nafcillin and Dicloxacillin - B-lactamase resistant
Penicillnase producing staph,
MSSA - methicillin susceptible s. aureus
prosthetic valve infection
Aminopenicillins - ampicillin and amoxicillin
drug of choice for pneumococci
shigella and other GI infections
Gonorrhea
Respiratory infections
Ticarcillin, Piperacillin, Azlocillin - extended spectrum
drug of choice for pseudomonas also for shigella and other GI bone and joint infections skin infections also used for lower respiratory and UTI where access is difficult
MoA of penicillins and cephalosporins
Inhibit transpeptidase PBP1a and PBP1b -> prevents D-ala removal on the 5th position
Absorption of Pen G
IV or IM because unstable in gastric acid - destroyed
Absorption of Nafcillin, ticarcillin, piperacillin
IV or IM because poor GI absorption
Pen V, Dicloxacillin, Ampicillin: special consideration when administered
can be given orally but food interferes with absorption
Elimination of Penicillin drugs
All unchanged in the urine Rapid elimination (30mins- 1.5hr) All except for amoxicillin have some biliary excretion Ticarcillin and piperacillin: biliary excretion is increased with renal deficiency
AE for penicillin drugs
Common:
NVD (increased risk with amoxicillin), Allergic reactions, phlebitis- inflammation of veins (Ticarcillin and piperacilin)
Rare:
neutropenia (pen G, nafcillin, piperacillin)
CNS effects (confusion, seizures)
Hyperkalemia (pen G K+)
dizziness, tinnitus, headache (Pen G procaine)
Special considerations for Penicillins
Increased risk of rash with amoxicillin with allopurinol
Pen G and V decrease effectiveness of birth control pills
Colestipol (cholesterol) decrease Pen V absorption
Probenecid (gout) increases plasma levels with pen G and V
Cephalosporins First generation
very active against gram (+) aerobic cocci Pen-sensitive staph and strep NOT active against enterococci little g(-) Cefazolin Cephalexin
Cephalosporins Second generation
active against g(+) aerobic cocci but not as much as 1st gen but has better g(-) mouth but not GI anaerobes Loracarbef Cefonicid cefaclor cefuroxime cefprozil cefazolin (parenteral)
3rd generation cephalosporin
inferior to 2nd and 1st for g(+) good against g(-) broad coverage of enterobacteria NO GI anaerobes cefixime cefotaxime Cefoperaxone (doesn't go to CNS & biliary excretion) Ceftriaxone (biliary excretion- reversible obstructive toxicity)
4th generation cephalosporin
less potent than 1st gen but more than 3rd gen against g(+) EXCELLENT against g(-)
better than 3rd gen!
cefeprime
Cephamycins
Cefoxitin
not “true” 2nd generation
less active against G(+) cocci
CAN GO AGAINST SOME ENTEROBACTERIA
Used: anaerobic/aerobic infections of the skin/ soft tissue
intra-abdominal or gynecological surgical prophylaxis
Clinical use of first generation cephalosporin
uncomplicated, community acquired skin and soft tissue infections and UTI
respiratory infection by PEN sensitive bacteria
surgical wound prophylaxis (parenteral)
Clinical use of 2nd generation cephalosporin
community acquired respiratory infection
uncomplicated UTI by E.coli
clinical use of 3rd generation cephalosporin
hospital acquired gram (-) infections
all kinds of complicated community acquired infections
lyme disease, severe shigella, typhoid fever
clinical use of 4th gen cephalosporin
moderate to sever nosocomial acquired infections
uncomplicated and complicated UTI, skin and soft tissue infections
Pneumonia bacteremia
MoA of cephalosporins
inhibit transpeptidase PBP1a, 1b, PBP3
Ceftobiprole Medocarila
broad spectrum cephalosporin derivative
high affinity for PBP2a for MRSA and PBP2x for resistant strep.
knocks everything down
T1/2 for 1st gen & 4th gen cephalosporins
1-2 hours
4th gen readily penetrate the CNS
T1/2 for 2nd gen & 3rd gen cephalosporins
wide range: 1-8hr